5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Seoul St. Mary's Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Yoo-Jin Kim, Seoul St. Mary's Hospital
ClinicalTrials.gov Identifier:
NCT01652781
First received: July 11, 2012
Last updated: July 25, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)